Swiss drug regulator clears use of Novavax's COVID shot in teens & as booster for adults

Sep. 02, 2022 2:27 PM ETNovavax, Inc. (NVAX)By: Anuron Mitra, SA News Editor7 Comments

Germany Begins Novavax Covid Vaccinations

Carsten Koall/Getty Images News

Novavax (NASDAQ:NVAX) on Friday said the Swiss drug regulator had expanded its temporary approval of its COVID-19 vaccine for use in teenagers aged 12 through 17 and as a booster dose for adults aged

Recommended For You

Comments (7)

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.